Kura Oncology, Inc. (KURA)
11.39
-0.18
(-1.56%)
USD |
NASDAQ |
Sep 11, 16:00
11.30
-0.09
(-0.79%)
After-Hours: 06:09
Kura Oncology Price to Book Value : 20.92 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 20.92 |
| September 10, 2026 | 21.25 |
| September 09, 2026 | 22.21 |
| September 08, 2026 | 23.00 |
| September 04, 2026 | 24.34 |
| September 03, 2026 | 24.15 |
| September 02, 2026 | 24.08 |
| September 01, 2026 | 23.68 |
| August 31, 2026 | 23.23 |
| August 28, 2026 | 23.25 |
| August 27, 2026 | 24.21 |
| August 26, 2026 | 23.99 |
| August 25, 2026 | 24.96 |
| August 24, 2026 | 22.78 |
| August 21, 2026 | 21.84 |
| August 20, 2026 | 21.51 |
| August 19, 2026 | 23.01 |
| August 18, 2026 | 22.65 |
| August 17, 2026 | 20.72 |
| August 14, 2026 | 19.95 |
| August 13, 2026 | 18.53 |
| August 12, 2026 | 18.26 |
| August 11, 2026 | 18.24 |
| August 10, 2026 | 18.09 |
| August 07, 2026 | 17.58 |
| Date | Value |
|---|---|
| August 06, 2026 | 17.04 |
| August 05, 2026 | 16.90 |
| August 04, 2026 | 17.39 |
| August 03, 2026 | 16.88 |
| July 31, 2026 | 16.55 |
| July 30, 2026 | 17.10 |
| July 29, 2026 | 16.40 |
| July 28, 2026 | 17.10 |
| July 27, 2026 | 18.64 |
| July 24, 2026 | 19.08 |
| July 23, 2026 | 19.19 |
| July 22, 2026 | 19.36 |
| July 21, 2026 | 20.00 |
| July 20, 2026 | 19.62 |
| July 17, 2026 | 19.95 |
| July 16, 2026 | 20.00 |
| July 15, 2026 | 20.81 |
| July 14, 2026 | 20.64 |
| July 13, 2026 | 20.04 |
| July 10, 2026 | 21.03 |
| July 09, 2026 | 22.19 |
| July 08, 2026 | 22.26 |
| July 07, 2026 | 22.02 |
| July 06, 2026 | 20.28 |
| July 02, 2026 | 20.39 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Inovio Pharmaceuticals, Inc. | 23.55 |
| Fortress Biotech, Inc. | 0.5114 |
| Syndax Pharmaceuticals, Inc. | 107.34 |
| Spero Therapeutics, Inc. | 1.486 |
| Gossamer Bio, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 13.02 |
| PEG Ratio | -0.0693 |
| Price | 11.39 |
| Earnings Yield | -29.52% |
| Market Cap | 1.013B |
| PEGY Ratio | -0.0693 |